Cro

2 months ago


Gandhidham, India Rusan Pharma Full time

**Roles and Responsibilities**

Quantys Clinical Pvt. Ltd. (Rusan Pharma) is Hiring for Business Development Executive
- CRO Having Experience of Minimum 02 Year
- 04 Year at Gandhidham Location.

**Position: Business Development Executive**

**Qualifications required: MBA / M Pharma/ B Pharma**

**Role & responsibilities**
- Actively prospect and generate new sales and business opportunities within assigned customer territory.
- Achieve business targets.
- Collaborate with internal staff regarding the development and procurement of proposals.
- Build long-term relationships with customers.
- Maintain and expand the relationship with clients and organization.
- Arrange business meeting with prospective.
- Be active in conferences to report business progress and status updates to clients and management.
- Promotes the companys services.
- Maintain and update customers data daily.
- Ensure clients satisfaction by delivering quality services.
- Maintain and expand the relationship with clients and organizations.

Skill:

- At least 2-4 years of previous experience in CRO
- **Travel**: 40-70%
- Good Communication Skills
- Extensive experience in Business Management
- High Communication Skills- Mo : 9913468943Role:
Business Development Executive (BDE)
- Salary:
Not Disclosed by Recruiter
- Industry:
Pharmaceutical & Life Sciences
- Department:
Sales & Business Development
- Role Category:
BD / Pre Sales
- Employment Type:
Full Time, Permanent
- Key Skills

business development

cro

Skills highlighted with ‘‘ are preferred keyskills
- Education
- UG:
Any Graduate

Company Profile
- Rusan Pharma
- Rusan is a research driven pharmaceutical company having its Manufacturing Units in India and Worldwide Marketing of Pharmaceutical Formulation, Active Pharmaceutical Ingredients and Intermediates. The company has its own Research & Development centre at Kandivli (west), Mumbai, state of the art, Bulk Manufacturing Plant at Ankleshwar and Formulation plant at Dehradun and SEZ, Kandla having approval of MHRA (UK), MCC (SA) and other International Health Authorities. March 2008 - 82 Crs., Expected by March 2009 €“ 150 Crs.

Contact Company:
Rusan Pharma

Website: